1-β-D-arabinofuranosylcytosine is cytotoxic in quiescent normal lymphocytes undergoing DNA excision repair

Japanese Journal of Cancer Research

Volumn 93, Issue 12, 2002, Pages 1334-1341

  Yamauchi, Takahiro ^a   Kawai, Yasukazu ^a   Ueda, Takonori ^a  

^a UNIVERSITY OF FUKUI   (Japan)

Author keywords

Ara C; BCNU; Comet assay; DNA repair; UV

Indexed keywords

CARMUSTINE; CYTARABINE; NUCLEOSIDE DERIVATIVE;

ACUTE LEUKEMIA; CELL CYCLE S PHASE; CELL KINETICS; COMET ASSAY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DNA DAMAGE; DNA SYNTHESIS INHIBITION; EXCISION REPAIR; HUMAN; HUMAN CELL; LYMPHOCYTE; LYMPHOCYTE SUBPOPULATION; PRIORITY JOURNAL; REVIEW; ULTRAVIOLET C RADIATION;

EID: 0036954293     PISSN: 09105050     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2002.tb01242.x     Document Type: Review

References (27)

1. Fukushima, T. and Ueda, T. Current situation and perspective for treatment of acute myelogenous leukemia in adults. Jpn. J. Cancer Chemother., 25, 295-302 (1998).
2. Press, O. W., Livingston, R., Mortimer, J., Collins, C. and Appelbaum, F. Treatment of relapsed non-Hodgkin's lymphomas with dexamethasone, high-dose cytarabine, and cisplatin before marrow transplantation. J. Clin. Oncol., 9, 423-431 (1991).
3. Graham, F. L. and Whitmore, G. F. The effect of 1-β-D-arabinofuranosylcytosine on growth, viability, and DNA synthesis of mouse L-cells. Cancer Res., 30, 2627-2635 (1970).
4. Graham, F. L. and Whitmore, G. F. Studies in mouse L-cells on the incorporation of 1-β-D-arabinofuranosylcytosine into DNA and on inhibition of DNA polymerase by 1-β-D-arabinofuranosylcytosine 5′-triphosphate. Cancer Res., 30, 2636-2644 (1970).
5. Chou, T.-C., Arlin, Z., Clarkson, B. D. and Philips, F. S. Metabolism of 1-β-D-arabinofuranosylcytosine in human leukemic cells. Cancer Res., 37, 3561-3570 (1977).
6. Spriggs, D., Robbins, G., Ohno, Y. and Kufe, D. Detection of 1-β-D-arabinofuranosylcytosine incorporation into DNA in vivo. Cancer Res., 47, 6532-6536 (1987).
7. Takauji, R., Tohyama, K., Ueda, T. and Nakamura, T. Enhancement of cytosine arabinoside cytotoxicity by granulocyte/macrophage colony-stimulating factor and granulocyte colony-stimulating factor in a human myeloblastic leukemia cell line. Jpn. J. Cancer Res., 84, 445-450 (1993).
8. Dunn, W. C. and Regan, J. D. Inhibition of DNA excision repair in human cells by arabinofuranosyl cytosine: effect on normal and xeroderma pigmentosum cells. Mol. Pharmacol., 15, 367-374 (1979).
9. Collins, A. R. S., Squires, S. and Johnson, R. T. Inhibitors of repair DNA synthesis. Nucleic Acids Res., 10, 1203-1213 (1982).
10. Ahnstrom, G. Inhibition of DNA strand break rejoining in ultraviolet-irradiated human cells: comparison of aphidicolin and cytosine arabinoside. Biochim. Biophys. Acta, 1007, 357-358 (1989).
11. Zittoun, J., Marquet, J. and David, J.-C. Mechanism of inhibition of DNA ligase in ara-C treated cells. Leuk. Res., 15, 157-164 (1991).
12. Wood, R. D. DNA repair in eukaryotes. Annu. Rev. Biochem., 65, 135-167 (1996).
13. Sancar, A. DNA excision repair. Annu. Rev. Biochem., 65, 43-81 (1996).
14. Lindahl, T. and Wood, R. D. Quality control by DNA repair. Science, 286, 1897-1905 (1999).
15. Sandoval, A., Consoli, U. and Plunkett, W. Fludarabine-mediated inhibition of nucleotide excision repair induces apoptosis in quiescent human lymphocytes. Clin. Cancer Res., 2, 1731-1741 (1996).
16. Yamauchi, T., Kawai, Y. and Ueda, T. Inhibition of nucleotide excision repair by fludarabine in normal lymphocytes in vitro, measured by the alkaline single cell gel electrophoresis (Comet) assay. Jpn. J. Cancer Res., 93, 567-573 (2002).
17. Thompson, L. H. 18 Nucleotide excision repair. In "DNA Damage and Repair, Vol. 2: DNA Repair in Higher Eukaryotes," ed. J. A. Nickoloff and M. F. Hoekstra, pp. 335-393 (1998). Humana Press, Inc., Ottawa.
18. Wiencke, J. K. and Wiemels, L. Genotoxicity of 1,3-bis(2-chloroethyl-1-nitrosourea (BCNU). Mutat. Res., 339, 91-119 (1995).
19. + human bone marrow progenitor cells. Mol. Pharmacol., 50, 610-615 (1996).
20. Koopman, G., Reutelingsperger, C. P., Kuijten, G. A., Keelmen, R. M., Pals, S. T. and van Oers, M. H. Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis. Blood, 84, 1415-1420 (1994).
21. Fallon, H. J., Frei, E., III, Davidson, J. D., Trier, J. S. and Burk, D. Leukocyte preparations from human blood: evaluation of their morphologic and metabolic state. J. Lab. Clin. Med., 59, 779-791 (1962).
22. Olive, P. L., Banath, J. P. and Durand, R. E. Heterogeneity in radiation-induced DNA damage and repair in tumor and normal cells measured using the "Comet" assay. Radiat. Res., 122, 86-94 (1990).
23. Tew, K. D., Colvin, M. and Chabner, B. A. Alkylating agents. In "Cancer Chemotherapy and Biotherapy," ed. B. A. Chabner and D. L. Longo, pp. 297-317 (1996). Lippincott-Raven Publishers, Philadelphia.
24. Ueda, T., Matsuyama, S., Yamauchi, T., Kishi, S., Fukushima, T., Tsutani, H., Nakamura, T., Gotoh, N. and Masada, M. Clinical pharmacology of intermediate and low-dose cytosine arabinoside (ara-C) therapy in patients with hematologic malignancies. Adv. Exp. Med. Biol., 431, 647-651 (1998).
25. Chaney, S. G. and Sancar, A. DNA repair: enzymatic mechanisms and relevance to drug response. J. Natl. Cancer Inst., 88, 1346-1360 (1996).
26. Esteller, M., Garcia-Foncillas, J., Andion, E., Goodman, S. N., Hidalgo, O. F., Vanaclocha, V., Baylin, S. B. and Herman, J. G. Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents. N. Engl. J. Med., 343, 1350-1354 (2000).
27. O'Brien, S. M., Kantarjian, H. M., Cortes, J., Beran, M., Koller, C. A., Giles, F. J., Lerner, S. and Keating, M. Results of the fludarabine and cyclophosphamide combination regimen in chronic lymphocytic leukemia. J. Clin. Oncol., 19, 1414-1420 (2001).